Navigation Links
Common blood pressure medication may pose risk to older adults
Date:6/16/2014

Dallas June 12, 2014 Adults over 65 who have recently begun thiazide diuretics are at a greater risk for developing metabolic-related adverse events, researchers at UTSouthwestern Medical Center have found.

More than two-thirds of older adults have high blood pressure in the United States and thiazide diuretics are often recommended as the initial medication for these hypertensive patients. Thiazide diuretics primarily inhibit sodium transport in the kidney, leading to urinary loss of sodium and water, which decreases blood pressure. While the risks of this medication are well known, the risks are not well quantified in real-world clinical practice, where older adults who are treated may have a number of other illnesses.

The national observational study, undertaken by a team of researchers at UTSouthwestern and the University of California, San Francisco, examined 1,060 adult veterans with hypertension who recently began taking a thiazide diuretic. The study compared them to a similar group of veterans who were not prescribed a thiazide diuretic. The findings were recently published in the Journal of the American Geriatrics Society.

During a nine month period, 14 percent of older adults prescribed a thiazide diuretic developed a metabolic adverse event, compared with 6 percent of adults not prescribed a thiazide diuretic. For every 12 adults who were newly prescribed a thiazide diuretic, one developed a metabolic adverse event that he or she would not otherwise have had.

The three metabolic adverse events that researchers assessed were hyponatremia (low sodium levels in the blood), hypokalemia (low potassium levels in the blood), and acute kidney injury (a 25 percent decrease in kidney function from the baseline value before the thiazide diuretic was started).

"Our research quantifies the risks of metabolic adverse events in older adults in real-world, clinical practice shortly after initiating thiazide diuretics," said Dr. Anil Makam, assistant professor of Internal Medicine at UTSouthwestern and first author of the study. "From a clinical point-of-view, the implications of these findings help inform doctors of the risks associated with a common medication and their use in older adults."

While the findings highlight that thiazide-related adverse events are common in this population, researchers were surprised to discover that only 42 percent of older adults who had recently begun taking a thiazide diuretic had laboratory testing to monitor for these adverse events within the first three months of beginning the medication.

"Our research suggests that thiazide-induced adverse events are common in older adults and greater attention should be paid to potential complications in prescribing thiazide diuretics to older adults, including closer laboratory monitoring before and after initiation of thiazides," Dr. Makam said.


'/>"/>
Contact: Lisa Warshaw
lisa.warshaw@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. Researchers uncover common heart drugs link to diabetes
2. Compounds in saliva and common body proteins may fend off DNA-damaging chemicals
3. Creatures of habit: Disorders of compulsivity share common pattern and brain structure
4. Gambling history is common among homeless people in Toronto, new study
5. Study debunks common myth that urine is sterile
6. Discovery links rare, childhood neurodegenerative diseases to common problem in DNA repair
7. Expert guidance strengthens strategies to prevent most common and costly infection
8. Complications from kidney stone treatments are common and costly
9. Unemployment common after breast cancer treatment
10. Vanderbilt study finds physical signs of depression common among ICU survivors
11. Pregnancy complications may be more common in immigrants from certain regions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common blood pressure medication may pose risk to older adults
(Date:1/23/2017)... ... January 23, 2017 , ... DMG ... Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, January 28, 2017 at ... was founded in 2008 to address the limitations of fatigue monitoring technologies within ...
(Date:1/23/2017)... ... ... plastic balance boards have been around since at least the 1950s and are a great ... and only balance board to use a patent-pending design featuring high-pressure inflation technology and drop-stitch ... well as skill-level adjustable for all ages and abilities. The board can be rolled ...
(Date:1/23/2017)... Grants Pass, OR (PRWEB) , ... January 23, 2017 , ... ... disease, took to the air to educate listeners about the benefits of making new ... in the U.S.,” Kleyne said, “it’s appropriate that we expect water infrastructure to become ...
(Date:1/23/2017)... ... January 23, 2017 , ... Zachary Cattell, ... serve as a healthcare industry expert at the 2017 Sector Summit hosted by ... Inside Indiana Business host Gerry Dick, will feature an employer and an association ...
(Date:1/23/2017)... ... 2017 , ... Moisture measurement is a necessary process step ... to success. Selecting an inappropriate measurement method can cause costly errors, and poor ... equipment. Rare or expensive substances are wasted and production may even be stopped ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 2017 7D Surgical announced today that ... U.S. Food and Drug Administration (FDA) and a ... North American commercial launch of its innovative Machine-vision ... the 7D Surgical System.  The ... and machine vision algorithms to eliminate the long-standing ...
(Date:1/23/2017)... DUBLIN , Jan 23, 2017 Research and ... Market Analysis & Trends - Product - Forecast to 2025" report ... Report Highlights: ... current and future market trends to identify the investment opportunities ... numbers Key market trends across the business segments, Regions ...
(Date:1/23/2017)... January 23, 2017 Varias ... enal) y el riesgo de ... a pabetalone    Resverlogix Corp. ("Resverlogix" ... preliminares de un ensayo en fase 1 con sede ... riñón (renal) severa. Los datos demostraron unos resultados importantes ...
Breaking Medicine Technology: